Published in Clin Exp Immunol on November 01, 2005
Alcohol and hepatitis C virus--interactions in immune dysfunctions and liver damage. Alcohol Clin Exp Res (2010) 1.77
Hepatitis C virus and alcohol. Semin Liver Dis (2009) 1.08
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals. J Hepatol (2010) 1.02
Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection. Clin Vaccine Immunol (2007) 0.89
Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes. BMC Cancer (2009) 0.83
Dendritic cell-based immunity and vaccination against hepatitis C virus infection. Immunology (2012) 0.83
Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cells. Clin Exp Immunol (2007) 0.82
Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells. J Viral Hepat (2010) 0.82
Hepatitis C virus modulates human monocyte-derived dendritic cells. J Viral Hepat (2010) 0.81
Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments. J Gastroenterol (2007) 0.81
Vaccination with dendritic cells pulsed with hepatitis C pseudo particles induces specific immune responses in mice. World J Gastroenterol (2012) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet (2001) 35.17
The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med (1992) 22.13
Hepatitis C virus infection. N Engl J Med (2001) 18.67
Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med (1999) 17.03
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med (1998) 14.40
Dendritic cells: specialized and regulated antigen processing machines. Cell (2001) 10.44
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology (2002) 9.35
Protection against persistence of hepatitis C. Lancet (2002) 5.94
Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med (2000) 5.58
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A (1999) 3.30
Sensing pathogens and tuning immune responses. Science (2001) 2.73
Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest (2002) 2.55
Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology (2001) 2.49
Cytotoxic T cells and viral hepatitis. J Clin Invest (1997) 2.46
Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol (1999) 2.44
Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology (2001) 2.38
Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood (2001) 2.26
Dendritic cells as vectors for therapy. Cell (2001) 2.18
Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology (2001) 1.94
Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol (2000) 1.93
Modulating the immune response with dendritic cells and their growth factors. Trends Immunol (2001) 1.66
Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol (1998) 1.51
Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology (2000) 1.49
Cell mediated immune response to the hepatitis C virus. Curr Top Microbiol Immunol (2000) 1.48
Strategies for an HIV vaccine. J Clin Invest (2002) 1.42
Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol (1997) 1.30
Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J Gastroenterol Hepatol (2000) 1.17
Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice. Hepatology (2001) 1.13
The HIV-1 vaccine race. Cell (2002) 1.08
Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J Immunol (1998) 1.01
Vaccine development for hepatitis C. Semin Liver Dis (2000) 0.94
Strategies and prospects for vaccination against the hepatitis C viruses. Curr Top Microbiol Immunol (2000) 0.92
Hepatitis C epidemiology. Curr Top Microbiol Immunol (2000) 0.92
Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology (1996) 0.91
Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model. Gastroenterology (2001) 0.90
DNA vaccines. Intervirology (1999) 0.89
Natural history and disease manifestations of hepatitis C infection. Curr Top Microbiol Immunol (2000) 0.88
Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein. Vaccine (2001) 0.80
Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? Nat Med (1996) 5.09
Replication strategy of human hepatitis B virus. J Virol (1987) 4.42
Long-term survival in patients with hereditary hemochromatosis. Gastroenterology (1996) 4.00
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med (1985) 3.73
The ras-related YPT1 gene product in yeast: a GTP-binding protein that might be involved in microtubule organization. Cell (1986) 3.40
Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J (1982) 3.32
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med (1995) 3.20
Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line. EMBO J (1987) 3.09
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med (1998) 2.91
Adenine nucleotide translocation of mitochondria. 1. Specificity and control. Eur J Biochem (1968) 2.91
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53
Macrolide-induced Churg-Strauss syndrome in a patient with atopy. Lancet (1997) 2.42
Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest (1997) 2.32
Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol (1989) 2.27
Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol (1998) 2.26
TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ (2005) 2.25
Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis. Endoscopy (2006) 2.24
[Correlation of the unspecific permeable mitochondrial space with the "intermembrane space"]. Eur J Biochem (1968) 2.18
Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis. Aliment Pharmacol Ther (2014) 2.15
DNA-binding activity is associated with purified myb proteins from AMV and E26 viruses and is temperature-sensitive for E26 ts mutants. Cell (1985) 2.11
Risk of infection with Helicobacter pylori and hepatitis A virus in different groups of hospital workers. Am J Gastroenterol (1997) 2.09
Putative reverse transcriptase intermediates of human hepatitis B virus in primary liver carcinomas. Science (1986) 2.00
Unspecific permeation and specific exchange of adenine nucleotides in liver mitochondria. Biochim Biophys Acta (1965) 2.00
Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest (1998) 1.86
Expression of hepatitis B antigens with a simian virus 40 vector. J Virol (1984) 1.80
Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study. Endoscopy (2008) 1.76
Adenine nucleotide translocation of mitochondria. Kinetics of the adenine nucleotide exchange. Eur J Biochem (1969) 1.75
Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol (1993) 1.73
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death Differ (2004) 1.62
Detection of an element of the SV40 late promoter in vectors used for expression studies in COS cells. EMBO J (1983) 1.57
Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci U S A (1985) 1.55
Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial. Hepatology (1996) 1.53
Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol (1994) 1.52
Late diagnosis of Wilson's disease in a case without onset of symptoms. Acta Neurol Scand (1995) 1.52
Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants. J Gen Virol (1998) 1.50
Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein. Proc Natl Acad Sci U S A (1986) 1.50
Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol (2001) 1.48
Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med (1998) 1.42
Criteria of viability of isolated liver cells. Hoppe Seylers Z Physiol Chem (1975) 1.40
Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect Immun (2001) 1.40
Establishment of persistent hepatitis C virus infection and replication in vitro. J Gen Virol (1997) 1.35
The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol (2005) 1.34
Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci (1997) 1.34
Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab (1997) 1.32
Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoElectrospray-tandem mass spectrometry. Scand J Gastroenterol (2004) 1.29
Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol (1998) 1.27
Hepatocellular influx of [14C]oleate reflects membrane transport rather than intracellular metabolism or binding. Proc Natl Acad Sci U S A (1986) 1.26
The response of the respiratory chain and adenine nucleotide system to oxidative phosphorylation in yeast mitochondria. Eur J Biochem (1967) 1.24
Mouse fatty acid transport protein 4 (FATP4): characterization of the gene and functional assessment as a very long chain acyl-CoA synthetase. Gene (2001) 1.24
Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia (1984) 1.23
Analysis of hepatitis C virus core protein interaction domains. J Gen Virol (1997) 1.21
Role of plasma membrane ligand-binding proteins in the hepatocellular uptake of albumin-bound organic anions. Hepatology (1987) 1.21
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology (1997) 1.20
Differences in the regulation of iron regulatory protein-1 (IRP-1) by extra- and intracellular oxidative stress. J Biol Chem (1997) 1.19
The glomerulosclerosis gene Mpv17 encodes a peroxisomal protein producing reactive oxygen species. EMBO J (1994) 1.18
Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem (1997) 1.17
Cleavage of oligoribonucleotides by the 2',5'-oligoadenylate- dependent ribonuclease L. J Biol Chem (1996) 1.17
Uptake of taurocholic acid into isolated rat-liver cells. Eur J Biochem (1975) 1.17
Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies. Immunology (1996) 1.17
Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J Clin Invest (1985) 1.16
Direct determination of Helicobacter pylori vacA genotypes and cagA gene in gastric biopsies and relationship to gastrointestinal diseases. Am J Gastroenterol (1999) 1.16
Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res Bull (2001) 1.14
Characterization of large surface proteins of hepatitis B virus by antibodies to preS-S encoded amino acids. Virology (1986) 1.12
Metabolic control in mitochondria by adenine nucleotide translocation. Biochem Soc Symp (1968) 1.11
Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate. Biochemistry (1994) 1.11
Physicochemical and immunohistological studies of a sulfobromophthalein- and bilirubin-binding protein from rat liver plasma membranes. J Clin Invest (1983) 1.10
Interleukin-6 expression and regulation in rat enteric glial cells. Am J Physiol Gastrointest Liver Physiol (2001) 1.10
A novel epitope for the specific detection of exogenous prion proteins in transgenic mice and transfected murine cell lines. Virology (1999) 1.09
Direct evidence for catalase as the predominant H2O2 -removing enzyme in human erythrocytes. Blood (1997) 1.08
Protein-mediated facilitated uptake processes for fatty acids, bilirubin, and other amphipathic compounds. Proc Soc Exp Biol Med (1996) 1.07
Point mutations within the betaG-betaH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells. J Virol (1997) 1.06
Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection. J Virol (1986) 1.06
Detection of pre-S1 proteins in serum and liver of HBsAg-positive patients: a new marker for hepatitis B virus infection. Hepatology (1986) 1.06
Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut (2003) 1.05
Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera. Virology (1987) 1.05
[Integrated skills laboratory concept for undergraduate training in internal medicine]. Dtsch Med Wochenschr (2005) 1.05
Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. J Hepatol (1998) 1.04
Red cell ouabain binding sites, Na+K+-ATPase, and intracellular Na+ as individual characteristics. Life Sci (1981) 1.04
Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors. Cancer Gene Ther (2001) 1.04
Vaccine-induced, pseudorabies virus-specific, extrathymic CD4+CD8+ memory T-helper cells in swine. J Virol (1998) 1.03
Detection of cattle-derived BSE prions using transgenic mice overexpressing bovine PrP(C). Arch Virol Suppl (2000) 1.02
Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol (1997) 1.02
Studies of albumin binding to rat liver plasma membranes. Implications for the albumin receptor hypothesis. Biochim Biophys Acta (1983) 1.01
Development of intrahepatic cholestasis by alpha-naphthylisothiocyanate in rats. Gastroenterology (1982) 1.00
Procalcitonin is a valid marker of infection in decompensated cirrhosis. Z Gastroenterol (2003) 1.00
IRP1 activation by extracellular oxidative stress in the perfused rat liver. J Biol Chem (2001) 1.00
Determination of catalase activity at physiological hydrogen peroxide concentrations. Anal Biochem (1997) 0.99
The mom gene of bacteriophage mu: a unique regulatory scheme to control a lethal function. Gene (1985) 0.99
No increase of biliary permeability in ethinylestradiol-treated rats. Gastroenterology (1983) 0.99
Temporary placement of fully covered self-expandable metal stents in biliary complications after liver transplantation. Endoscopy (2012) 0.99
Inhibition of DNA binding of purified p55v-myc in vitro by antibodies against bacterially expressed myc protein and a synthetic peptide. EMBO J (1984) 0.98
HJV gene mutations in European patients with juvenile hemochromatosis. Clin Genet (2005) 0.98
Studies of oleate binding to rat liver plasma membranes. Biochem Biophys Res Commun (1983) 0.98
Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. Eur J Clin Invest (2000) 0.97
Inhibition of HIV-1 reverse transcriptase by a quinazolinone and comparison with inhibition by pyridinones. Differences in the rates of inhibitor binding and in synergistic inhibition with nucleoside analogs. J Biol Chem (1994) 0.97
Iron uptake by human upper small intestine microvillous membrane vesicles. Indication for a facilitated transport mechanism mediated by a membrane iron-binding protein. J Clin Invest (1990) 0.96
On the mechanisms of ATP-induced and succinate-induced redistribution of cations in isolated rat liver cells. Eur J Biochem (1983) 0.96
The hepatic microvascular responses to sepsis. Semin Thromb Hemost (2000) 0.94